InSightec's Series D Round

InSightec raised a round of funding on July 01, 2014. Investors include York Capital Management.

InSightec provides non-invasive therapy platforms, Exablate and Exablate Neuro, which are proven technology based on sound clinical evidence for treating essential tremor, painful bone metastases and …

Articles about InSightec's Series D Round: